Vanguard Group Inc Molecular Templates, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.54 $858 - $1,188	-2,201 Reduced 0.1%	2,209,854 $1.06 Million
Q4 2022 Feb 10, 2023	SELL	$0.33 - $12.0 $34,089 - $1.24 Million	-103,301 Reduced 4.46%	2,212,055 $729,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $11.25 $67,968 - $1.12 Million	-99,953 Reduced 4.14%	2,315,356 $1.74 Million
Q2 2022 Aug 12, 2022	SELL	$0.81 - $3.43 $155,329 - $657,753	-191,765 Reduced 7.36%	2,415,309 $2.2 Million
Q1 2022 May 13, 2022	SELL	$2.27 - $4.13 $27,775 - $50,534	-12,236 Reduced 0.47%	2,607,074 $8.99 Million
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $410,206 - $836,237	-121,723 Reduced 4.44%	2,619,310 $10.3 Million
Q3 2021 Nov 12, 2021	BUY	$5.78 - $7.86 $277,746 - $377,696	48,053 Added 1.78%	2,741,033 $18.4 Million
Q2 2021 Aug 13, 2021	BUY	$7.82 - $12.44 $21.1 Million - $33.5 Million	2,692,980 New	2,692,980 $21.1 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.